RhumbLine Advisers’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.45M | Buy |
|
|||||
|
2025
Q1 | $1.4M | Buy |
|
|||||
|
2024
Q4 | $1.09M | Buy |
|
|||||
|
2024
Q3 | $900K | Sell |
|
|||||
|
2024
Q2 | $682K | Buy |
|
|||||
|
2024
Q1 | $558K | Buy |
|
|||||
|
2023
Q4 | $831K | Buy |
|
|||||
|
2023
Q3 | $873K | Buy |
|
|||||
|
2023
Q2 | $1.06M | Sell |
|
|||||
|
2023
Q1 | $1.57M | Buy |
|
|||||
|
2022
Q4 | $1.31M | Buy |
|
|||||
|
2022
Q3 | $1.21M | Buy |
|
|||||
|
2022
Q2 | $1.3M | Buy |
|
|||||
|
2022
Q1 | $1.34M | Sell |
|
|||||
|
2021
Q4 | $2.9M | Buy |
|
|||||
|
2021
Q3 | $3.35M | Sell |
|
|||||
|
2021
Q2 | $4.08M | Buy |
|
|||||
|
2021
Q1 | $3.09M | Sell |
|
|||||
|
2020
Q4 | $5.08M | Buy |
|
|||||
|
2020
Q3 | $4.08M | Buy |
|
|||||
|
2020
Q2 | $3.88M | Buy |
|
|||||
|
2020
Q1 | $1.67M | Buy |
|
|||||
|
2019
Q4 | $469K | Buy |
|
|||||
|
2019
Q3 | $351K | Buy |
|